Cosmos Health - COSM Company Value to Revenue

Cosmos Health (COSM) - corporate logo

Cosmos Health Inc. generates revenue through the sale of branded pharmaceuticals, Sky Premium Life vitamins, and European wholesale trade. The company's price-to-sales dynamics clearly demonstrate market expectations, with 385.46 representing the latest level. While revenues are based on scaling the network within the EU, high debt leverage and promotion costs for its own nutraceuticals create significant risks.

Cosmos Health Inc. (COSM): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

COSM (cosmosholdingsinc.com): analytical breakdowns and indicator data

Initial company analysis:COSM (Cosmos Health)
Manufactured product of Cosmos Health Inc.

Cosmos Health Inc. leverages extensive European distribution and steady demand for its generic portfolio, ensuring a stable cash flow. The EV/Sales trajectory reflects the total enterprise value, including net debt, relative to annual revenue, allowing investors to determine whether the asset is overvalued relative to actual sales or if a low multiple masks a fundamental degradation of the company.